Andreas Nilsson

Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge

Lei Si, Michael Willis, Christian Asseburg et al. · Value in Health · 2020 · 44 citations · Full text

Pharmacy, Economics, Pharmacoeconomics +16

Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM)

Michael Willis, Pierre Johansen, Andreas Nilsson et al. · PharmacoEconomics · 2016 · 40 citations

Pharmacy, Economics, Pharmacoeconomics +13

Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model

Michael Willis, Andreas Nilsson, Klas Kellerborg et al. · Diabetes Therapy · 2020 · 35 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Multivariate Prediction Equations for HbA 1c Lowering, Weight Change, and Hypoglycemic Events Associated with Insulin Rescue Medication in Type 2 Diabetes Mellitus: Informing Economic Modeling

Michael Willis, Christian Asseburg, Andreas Nilsson et al. · Value in Health · 2016 · 33 citations

Medicine, Biostatistics, Pharmacoeconomics +14

Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Economics and Health Outcomes Model of T2DM

Michael Willis, Adam Fridhammar, Jens Gundgaard et al. · PharmacoEconomics · 2020 · 29 citations · Full text

Pharmacy, Health Sciences, Pharmacoeconomics +17